PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2141
https://www.valueinhealthjournal.com/article/S1098-3015(12)03855-7/fulltext
Title :
PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03855-7&doi=10.1016/j.jval.2012.08.2141
First page :
A427
Section Title :
Cancer
Open access? :
No
Section Order :
794